Research and development
Our ambitious programmes aim to substantially reduce global epidemic and pandemic risk. CEPI’s priority diseases include Chikungunya, COVID-19, Ebola, Lassa Fever, MERS, Mpox, Nipah, Rift Valley Fever, and novel viral threats with epidemic or pandemic potential (also known as “Disease X”).
Enabling science
From biological standards to preclinical models, CEPI supports enabling science activities to accelerate the development of safe and effective vaccines.
Biosecurity
CEPI’s inaugural Biosecurity Strategy—supported by funding from Global Affairs Canada—aims to bolster global health security, underscoring its commitment to tackling emerging epidemic and pandemic threats, whether they arise naturally, accidentally or through deliberate misuse.
CEPI Technical Resources Hub
CEPI’s Technical Resources Hub is an open-access platform that aims to equip vaccine researchers, developers and funders with tools, methods, and knowledge to advance epidemic preparedness innovations.
Artificial intelligence
AI is revolutionising how science can protect the world and its people against the threat of infectious disease outbreaks. Learn how CEPI is harnessing the power of AI to transform vaccine development for future epidemics or pandemics.
Biosecurity
CEPI’s inaugural Biosecurity Strategy—supported by funding from Global Affairs Canada—aims to bolster global health security, underscoring its commitment to tackling emerging epidemic and pandemic threats, whether they arise naturally, accidentally or through deliberate misuse.
Call for Proposals
We invite innovators worldwide to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Apply now
Latest News
New experts appointed to CEPI’s Scientific Advisory Committee
The lab scientists banding together to test new outbreak-busting vaccines
CEPI 3.0 explained: Platform technologies
